PTX 0.00% 4.1¢ prescient therapeutics limited

Ann: PTX-100 trial advances following successful Phase 1b, page-273

  1. 7,912 Posts.
    lightbulb Created with Sketch. 3386
    Hey, Deno, what you may find a particularly interesting read is the following:

    Prescient Therapeutics Acquires Exclusive Worldwide Licence for Cancer Biomarker p27 - Wholesale Investor

    Be sure to download and read the PDF. Its fascinating stuff particularly given that we don't know what types of solid turmors make up the 5 cohorts in our trial. And, given that we know Prof Miles Prince had at least 2 of his own patients here in Aust that responded really well in the trial. I'm certainly not going to be throwing my conjectural thoughts out there for fear of casting aspersions.

    I happened to read an article today too in my Google feed relating to small biotech companies having a habit of not releasing all the detailed data of clinical results. In the case of our recent results and what is stated by Steven in the preso, I think all bodes well here!


    Last edited by Shellbell: 02/08/21
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
0.000(0.00%)
Mkt cap ! $33.01M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $9.056K 226.3K

Buyers (Bids)

No. Vol. Price($)
5 246262 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 160522 3
View Market Depth
Last trade - 16.10pm 17/09/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.